FIELD: pharmacology.
SUBSTANCE: invention relates to a pharmaceutical antidiabetic composition based on (+)-cis-3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentane carboxylic acid, characterized in that it comprises microcrystalline cellulose 102, Povidone K30, croscarmellose sodium, magnesium stearate and talc as pharmaceutically acceptable excipients.
EFFECT: increased bioavailability of the formulation active agent.
2 cl, 3 dwg, 4 ex
Authors
Dates
2017-07-07—Published
2016-05-16—Filed